HPV genotype-specific prevalence stratified by HIV
| HIV negative | HIV positive | HIV positive/HIV negative PRR (95% CI) | |||
| HPV positive | HPV positive | ||||
| n=978 | % | n=421 | % | ||
| Any HPV (LR and HR) | 596 | 60.94 | 382 | 90.74 | 1.49 (1.40 to 1.58) |
| Any LR-HPV | 449 | 45.91 | 348 | 82.66 | 1.80 (1.66 to 1.95) |
| Any HR-HPV | 378 | 38.65 | 312 | 74.11 | 1.92 (1.74 to 2.11) |
| LR-HPV genotype | |||||
| 6 | 51 | 5.21 | 72 | 17.1 | 3.28 (2.33 to 4.61) |
| 11 | 65 | 6.65 | 79 | 18.76 | 2.82 (2.08 to 3.84) |
| HR-HPV genotype | |||||
| 16 | 76 | 7.77 | 84 | 19.95 | 2.57 (1.92 to 3.42) |
| 18 | 37 | 3.78 | 57 | 13.54 | 3.58 (2.40 to 5.33) |
| 31 | 41 | 4.19 | 40 | 9.50 | 2.27 (1.49 to 3.45) |
| 33 | 28 | 2.86 | 44 | 10.45 | 3.65 (2.30 to 5.78) |
| 35 | 38 | 3.89 | 75 | 17.81 | 4.58 (3.15 to 6.66) |
| 39 | 28 | 2.86 | 43 | 10.21 | 3.57 (2.48 to 5.66) |
| 45 | 51 | 5.21 | 56 | 13.30 | 2.55 (1.78 to 3.66) |
| 51 | 68 | 6.95 | 70 | 16.63 | 2.39 (1.75 to 3.27) |
| 52 | 49 | 5.01 | 44 | 10.45 | 2.09 (1.41 to 3.08) |
| 56 | 17 | 1.74 | 29 | 6.89 | 3.96 (2.20 to 7.13) |
| 58 | 45 | 4.60 | 87 | 20.67 | 4.49 (3.19 to 6.32) |
| 59 | 49 | 5.01 | 77 | 18.29 | 3.65 (2.60 to 5.13) |
| 66 | 37 | 3.78 | 47 | 11.16 | 2.95 (1.95 to 4.47) |
| 68 | 39 | 3.99 | 71 | 16.86 | 4.23 (2.91 to 6.14) |
| Number of concurrent HR-HPV genotypes | |||||
| 0 | 600 | 61.35 | 109 | 25.89 | 0.42 (0.36 to 0.50) |
| 1 | 244 | 24.95 | 114 | 27.08 | 1.09 (0.90 to 1.31) |
| 2 | 82 | 8.38 | 69 | 16.39 | 1.95 (1.45 to 2.64) |
| 3+ | 52 | 5.32 | 129 | 30.64 | 5.76 (4.27 to 7.79) |
HPV, human papillomavirus; HR-HPV, high-risk human papillomavirus; LR-HPV, low-risk human papillomavirus; PRR, prevalence risk ratio.